SCHEMBL470207

SCHEMBL470207

COc1ccccc1-c1noc(C)c1C=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 2/20 0.48
HTR7 P34969 1/20 0.46
GHSR Q92847 1/20 0.46
ALDH1A1 P00352 7/20 0.45
NR3C1 P04150 1/20 0.43
PGR P06401 1/20 0.43
ERN1 O75460 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 4/20 0.42
RAB9A P51151 3/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
CASP6 P55212 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12694223 0.87 TP53 (0.45) GPBAR1ALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL21752798 0.83 S1PR1 (0.43) GPBAR1ALDH1A1L3MBTL1POLBNPSR1
SCHEMBL27927956 0.79 ESR1 (0.48) ERN1SMN1; SMN2NPC1RAB9ATP53
SCHEMBL27936743 0.79 PTGS1 (0.50) GPBAR1HTR7ALDH1A1SMN1; SMN2NPC1
SCHEMBL3724318 0.79 PTGS1 (0.57) GPBAR1ALDH1A1MAPTL3MBTL1HSD17B10
SCHEMBL12694208 0.77 LMNA (0.40) GPBAR1ALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL27927967 0.77 PLK1 (0.39) GPBAR1ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL457431 0.75 GPBAR1 (0.62) GPBAR1GHSRALDH1A1NPC1KDM4E
SCHEMBL30394156 0.75 GPBAR1 (0.62) GPBAR1GHSRALDH1A1NPC1KDM4E
SCHEMBL21752793 0.75 GPBAR1 (0.49) GPBAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033736-A1 NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed